Rufloxacin hydrochloride

• CAT Number: I000304
• CAS Number: 106017-08-7
• Molecular Formula: C17H19ClFN3O3S
• Molecular Weight: 399.87
• Purity: ≥95%
• Solubility: DMSO: 50 mg/mL
• Storage: Store at -20°C
• IUPAC Name: 7-fluoro-6-(4-methylpiperazin-1-yl)-10-oxo-4-thia-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid;hydrochloride
• InChI: InChI=1S/C17H18FN3O3S.ClH/c1-19-2-4-20(5-3-19)14-12(18)8-10-13-16(14)25-7-6-21(13)9-11(15(10)22)17(23)24;/h8-9H,2-7H2,1H3,(H,23,24);1H
• InChIKey: LPQOADBMXVRBNX-UHFFFAOYSA-N
• SMILES: CN1CCN(CC1)C2=C(C=C3C4=C2SCCN4C=C(C3=O)C(=O)O)F.Cl

Rufloxacin hydrochloride (Cat No.:I000304) is a fluoroquinolone antibiotic that exhibits potent antibacterial activity against a broad spectrum of gram-positive and gram-negative bacteria. Its pharmacologic action involves inhibiting bacterial DNA gyrase, an essential enzyme for DNA replication and repair, thus interfering with bacterial growth and replication. Rufloxacin hydrochloride is primarily used to treat various infections, including respiratory tract infections, urinary tract infections, and skin and soft tissue infections. With its broad-spectrum activity and favorable pharmacokinetic profile, rufloxacin hydrochloride has found application in both community and hospital settings, providing an effective therapeutic option for bacterial infections.